Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-03

FDA Approved: NITAZOXANIDE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' original application for nitazoxanide, a generic treatment for infections caused by Giardia lamblia and Cryptosporidium parvum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

ORIG AP for NITAZOXANIDE (NITAZOXANIDE)